Endurant Capital Management’s American Renal Associates Holdings, Inc ARA Stock Holding History

Endurant Capital Management’s Portfolio ARA Stock Details ARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-18,340	Closed	-$397K	–	79
2018 Q3	$397K	Buy	+18,340	New	+$347K	0.18%	68
2018 Q1	–	Sell	-89,129	Closed	-$1.55M	–	89
2017 Q4	$1.55M	Sell	89,129 -6,827	-7%	-$94.2K	0.47%	50
2017 Q3	$1.44M	Buy	95,956 +1,548	+2%	+$24.3K	0.44%	60
2017 Q2	$1.75M	Buy	94,408 +48,430	+105%	+$842K	0.5%	51
2017 Q1	$776K	Buy	+45,978	New	+$917K	0.25%	71
2016 Q3	–	Sell	-8,500	Closed	-$246K	–	107
2016 Q2	$246K	Buy	+8,500	New	+$237K	0.08%	83

Other funds holding ARA

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WIC

Whitegate Investment Counselors Concord, New Hampshire $315M AUM 10.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Endurant Capital Management's ARA Position: Q4 2018 in Review

Endurant Capital Management sold out of American Renal Associates Holdings, Inc (ARA) in Q4 2018, closing a stake of 18,340 shares — an estimated $397K sold.

Endurant Capital Management first reported a position in ARA in Q2 2016 and held it in 6 quarters. The position peaked at $1.75M in Q2 2017. 82 funds tracked by Wall St. Rank hold ARA as of Q4 2018.

Endurant Capital Management reported no remaining American Renal Associates Holdings, Inc position as of Q4 2018 after selling out during the quarter.
Endurant Capital Management sold 18,340 American Renal Associates Holdings, Inc shares in Q4 2018, an estimated $397K.
Endurant Capital Management first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 6 quarters.
Endurant Capital Management's American Renal Associates Holdings, Inc position peaked at $1.75M in Q2 2017.
82 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q4 2018.

Based on Endurant Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.